Incyte Corporation has raised its full-year 2026 Opzelura net sales guidance to between $1.05 billion and $1.1 billion following a landmark settlement with the Centers for Medicare & Medicaid Services. The agreement
Kelly Grigsby Jones and Laurie Avery, both litigation partners at Perez Morris, have opened up about what it genuinely takes to forge a lasting career in trial law. The two partners trace
More
London stocks closed sharply higher on Friday, buoyed by reports that fresh peace negotiations between the US and Iran could be back on the table. The FTSE 100 index ended the session
More
London Halloween parties are much bigger now than they were ten years ago. It isn’t just kids going door-to-door anymore. Adults go to big club nights, pub crawls, and house parties all
More
Verizon Communications missed Wall Street revenue expectations in the second quarter of 2026, raising fresh questions about growth momentum at one of America’s largest telecoms. The shortfall marks a notable stumble for
More
Nothing, the Kings Cross-based smartphone company founded by Carl Pei, has begun laying off staff across its global workforce as part of a cost-cutting drive. The company, which employs around 800 people
More
On July 17, 2026, the U.S. Department of Homeland Security published a final rule eliminating the long-standing “duration of status” framework for certain nonimmigrants. The rule affects F-1 students, J-1 exchange visitors,
More
Tom Goldstein, the founder of SCOTUSBlog, is scheduled to be sentenced today in a case that has drawn significant attention across the legal community. In a development that reads more like a
More
RELX PLC (LSE:REL) is beginning to silence its critics by demonstrating that artificial intelligence could accelerate growth rather than undermine its core business model. Following strong first-half results from the FTSE 100
More
The US stock market has shown tentative signs of stabilisation in recent sessions, with investors cautiously debating whether the worst of the recent selloff is over. For contrarian investors willing to bet
More
India-based active pharmaceutical ingredient makers Jagsonpal Pharmaceuticals and Tyche Industries have each received warning letters from the US Food and Drug Administration. Both companies were also placed on the FDA’s import alert
More